Measurement of kidney perfusion in critically ill Patients

Critical Care

Volumn 17, Issue 2, 2013, Pages

  Schneider, Antione G ^a,b   Goodwin, Mark D ^a   Bellomo, Rinaldo ^a,b  

^a AUSTIN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIPPURIC ACID; MICROSPHERE;

ACUTE KIDNEY FAILURE; BLOOD FLOW VELOCITY; BOLD SIGNAL; CONTRAST ENHANCEMENT; CRITICALLY ILL PATIENT; DOPPLER FLOWMETRY; ECHOGRAPHY; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; KIDNEY SCINTISCANNING; MICROCIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SAFETY; SPIN LABELING; THERMODILUTION; VASCULARIZATION; ACUTE KIDNEY INJURY; CRITICAL ILLNESS; HUMAN; KIDNEY; KIDNEY CIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; BLOOD FLOW VELOCITY; CRITICAL ILLNESS; HUMANS; KIDNEY; RENAL CIRCULATION;

EID: 84875364399     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12529     Document Type: Review

References (75)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . Beginning and Ending Supporting Therapy for the Kidney (BEST Kidney) Investigators Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, Beginning and Ending Supporting Therapy for the Kidney (BEST Kidney) Investigators.
2. Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008, 23:1203-1210.
3. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998, 104:343-348. 10.1016/S0002-9343(98)00058-8, 9576407.
4. Parikh A, Shaw A. The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin 2012, 28:99-111. 10.1016/j.ccc.2011.10.006, 22123102.
5. Bywaters EG, Beall D. Crush injuries with impairment of renal function. BMJ 1941, 1:427-432. 10.1136/bmj.1.4185.427, 2161734, 20783577.
6. Darmady EM. Renal anoxia and the traumatic uraemia syndrome. Br J Surg 1947, 34:262-271. 10.1002/bjs.18003413505, 20289112.
7. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169. 10.1056/NEJMra032401, 15247356.
8. Prowle JR, Ishikawa K, May CN, Bellomo R. Renal blood flow during acute renal failure in man. Blood Purif 2009, 28:216-225. 10.1159/000230813, 19648741.
9. Ishikawa K, Calzavacca P, Bellomo R, Bailey M, May CN. Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis. Crit Care Med 2012, 40:2368-2375. 10.1097/CCM.0b013e3182514be9, 22622397.
10. Morimatsu H, Ishikawa K, May CN, Bailey M, Bellomo R. The systemic and regional hemodynamic effects of phenylephrine in sheep under normal conditions and during early hyperdynamic sepsis. Anesth Analg 2012, 115:330-342. 10.1213/ANE.0b013e31825681ab, 22584559.
11. O'Connor PM, Evans RG. Structural antioxidant defense mechanisms in the mammalian and no nmammalian kidney: different solutions to the same problem?. Am J Physiol Reg Integ Comp Physiol 2010, 299:R723-R727.
12. Rudolph AM, Heymann MA. Validation of the antipyrine method for measuring fetal umbilical blood flow. Circ Res 1967, 21:185-190. 10.1161/01.RES.21.2.185, 4283644.
13. McDevitt DG, Nies AS. Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res 1976, 10:494-498. 10.1093/cvr/10.4.494, 947337.
14. Mendell PL, Hollenberg NK. Cardiac output distribution in the rat: comparison of rubidi um and microsphere methods. Am J Physiol 1971, 221:1617-1620.
15. Prinzen FW, Bassingthwaighte JB. Blood flow distributions by microsphere deposition methods. Cardiovasc Res 2000, 45:13-21. 10.1016/S0008-6363(99)00252-7, 3483311, 10728307.
16. Leivestad T, Brodwall EK, Simonsen S. Determination of renal blood flow by thermodilutio n method. Scand J Clin Lab Invest 1978, 38:495-499. 10.3109/00365517809108456, 705231.
17. Hornych A, Brod J, Slechta V. The measurement of the renal venous outflow in man by the local thermodilution method. Nephron 1971, 8:17-32. 10.1159/000179903, 4949644.
18. Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990, 98:170-179. 10.1378/chest.98.1.170, 2361386.
19. Sward K, Valsson F, Sellgren J, Ricksten SE. Bedside estimation of absolute renal blood flow and glomerular filtration rate in the intensive care unit. A validation of two independent methods. Intensive Care Med 2004, 30:1776-1782.
20. Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005, 31:79-85. 10.1007/s00134-004-2490-3, 15565364.
21. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE. Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 2011, 37:60-67. 10.1007/s00134-010-2057-4, 20949349.
22. Redfors B, Bragadottir G, Sellgren J, Sward K, Ricksten SE. Dopamine increases renal oxygenation: a clinical study in post-cardiac surgery patients. Acta Anaesthesiol Scand 2010, 54:183-190. 10.1111/j.1399-6576.2009.02121.x, 19764906.
23. Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, Merrill JP. Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators. Medicine 1975, 54:29-44. 10.1097/00005792-197501000-00002, 235062.
24. Hollenberg NK, Sandor T. Vasomotion of renal blood flow in essential hypertension. Oscillations in xenon transit. Hypertension 1984, 6:579-585. 10.1161/01.HYP.6.4.579, 6746087.
25. Hollenberg NK, Sandor T, Holtzman E, Meyerovitz MF, Harrington DP. Renal vasomotion in essential hypertension: influence of vasodilators. Hypertension 1989, 14:9-13. 10.1161/01.HYP.14.1.9, 2737740.
26. Elkayam U, Mehra A, Cohen GTummala PP, Karaalp IS, Wani OR, Canetti M. Renal circulatory effects of adenosine in patients with chronic heart failure. J Am Coll Cardiol 1998, 32:211-215. 10.1016/S0735-1097(98)00191-0, 9669272.
27. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992, 85:1899-1911. 10.1161/01.CIR.85.5.1899, 1572046.
28. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99 m MAG3 as a hippuran replacement. J Nucl Med 1986, 27:111-116.
29. Itoh K. 99mTc-MAG3: review of pharmacokinetics, clinical application to renal diseases and quantification of renal function. Ann Nucl Med 2001, 15:179-190. 10.1007/BF02987829, 11545186.
30. Trejtnar F, Laznicek M. Analysis of renal handling of radiopharmaceuticals. Q J Nucl Med 2002, 46:181-194.
31. Hilson AJ, Maisey MN, Brown CB, Ogg CS, Bewick MS. Dynamic renal transplant imaging with Tc-99 m DTPA (Sn) supplemented by a transplant perfusion index in the management of renal transplants. J Nucl Med 1978, 19:994-1000.
32. Peters AM, Gunasekera RD, Lavender JP, Myers MJ, Gordon I, Ash JM, Gilday DL. Noninvasive measurement of renal blood flow using DTPA. Contrib Nephrol 1987, 56:26-30.
33. Jafri RA, Britton KE, Nimmon CC, Solanki K, Al-Nahhas A, Bomanji J, Fettich J, Hawkins LA. Technetium-99 m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders. J Nucl Med 1988, 29:147-158.
34. Verbruggen AM, Nosco DL, Van Nerom CG, Bormans GM, Adriaens PJ, De Roo MJ. Technetium-99 m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 1992, 33:551-557.
35. Gates GF. Glomerular filtration rate: estimation from fractional renal accumulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol 1982, 138:565-570. 10.2214/ajr.138.3.565, 7039273.
36. Fawdry RM, Gruenewald SM, Collins LT, Roberts AJ. Comparative assessment of techniques for estimation of glomerular filtration rate with 99mTc-DTPA. Eur J Nucl Med 1985, 11:7-12. 10.1007/BF00440953, 3899658.
37. Haufe SE, Riedmuller K, Haberkorn U. Nuclear medicine procedures for the diagnosis of acute and chronic renal failure. Nephron Clin Pract 2006, 103:c77-c84. 10.1159/000091576, 16543760.
38. Mullani NA, Ekas RD, Marani S, Kim EE, Gould KL. Feasibility of measuring first pass extraction and flow with rubidium-82 in the kidneys. Am J Physiol Imaging 1990, 5:133-140.
39. Tamaki N, Rabito CA, Alpert NM, Yasuda T, Correia JA, Bartai-Kovach M, Kanke M, Dragotakes SC, Strauss HW. Serial analysis of renal blood flow by positron tomography with rubidium-82. Am J Physiol 1986, 251:H1024-H1030.
40. Szabo Z, Xia J, Mathews WB, Brown PR. Future direction of renal positron emission tomography. Semin Nucl Med 2006, 36:36-50. 10.1053/j.semnuclmed.2005.08.003, 1479802, 16356795.
41. Juillard L, Janier MF, Fouque D, Lionnet M, Le Bars D, Cinotti L, Bathez P, Gharib C, Laville M. Renal blood flow measurement by positron emission tomography using 15O-labeled water. Kidney Int 2000, 57:2511-2518. 10.1046/j.1523-1755.2000.00110.x, 10844620.
42. Alpert NM, Rabito CA, Correia DJ, babich JW, Littman BH, Tompkins RG, Rubin NT, Rubin RH, Fischman AJ. Mapping of local renal blood flow with PET and H(2)(15)O. J Nucl Med 2002, 43:470-475.
43. Vallee JP, Lazeyras F, Khan HG, Terrier F. Absolute renal blood flow quantification by dynamic MRI and Gd-DTPA. Eur Radiol 2000, 10:1245-1252. 10.1007/s003300000434, 10939483.
44. Marckmann P, Skov L, Rossen K, Dupont MB, Heaf JG, Thomson HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006, 17:2359-2362. 10.1681/ASN.2006060601, 16885403.
45. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 2009, 4:461-469. 10.2215/CJN.06011108, 19201920.
46. Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG. Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?. Kidney Int 2009, 75:465-474. 10.1038/ki.2008.496, 2643331, 18843256.
47. Debatin JF, Ting RH, Wegmuller H, Sommer FG, Fredrickson JO, Brosnan TJ, Myers BD, Herfkens RJ, Pelc NJ. Renal artery blood flow: quantitation with phase-contrast MR imaging with and without breath holding. Radiology 1994, 190:371-378.
48. Sommer G, Corrigan G, Fredrickson J, Sawyer-Glover A, Liao JR, Myers B, Pelc N. Renal blood flow: measurement in vivo with rapid spiral MR imaging. Radiology 1998, 208:729-734.
49. Prowle JR, Molan MP, Hornsey E, Bellomo R. Cine phase-contrast magnetic resonance imaging for the measurement of renal blood flow. Contrib Nephrol 2010, 165:329-336.
50. Wolf RL, King BF, Torres VE, Wilson DM, Ehman RL. Measurement of normal renal artery blood flow: cine phase-contrast MR imaging vs clearance of p-aminohippurate. AJR Am J Roentgenol 1993, 161:995-1002. 10.2214/ajr.161.5.8273644, 8273644.
51. de Haan MW, Kouwenhoven M, Kessels AG, van Engelshoven JM. Renal artery blood flow: quantification with breath-hold or respiratory triggered phase-contrast MR imaging. Eur Radiol 200, 10:1133-1137.
52. King BF, Torres VE, Brummer ME, Chapman AB, Bae KT, Glockner JF, Arya K, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP, . Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney Int 2003, 64:2214-2221. 10.1046/j.1523-1755.2003.00326.x, 14633145, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
53. Prowle JR, Molan MP, Hornsey E, Bellomo R. Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation. Crit Care Med 2012, 40:1768-1776. 10.1097/CCM.0b013e318246bd85, 22487999.
54. Golay X, Hendrikse J, Lim TC. Perfusion imaging using arterial spin labeling. Top Magn Reson Imaging 2004, 15:10-27. 10.1097/00002142-200402000-00003, 15057170.
55. Artz NS, Sadowski EA, Wentland AL, Grist TM, Seo S, Djamali A, Fain SB. Arterial spin labeling MRI for assessment of perfusion in native and transplanted kidneys. Magn Reson Imaging 2011, (29):74-82.
56. Spuentrup E, Manning WJ, Bornert P, Kissinger KV, Botnar RM, Stuber M. Renal arteries: navigator-gated balanced fast field-echo projection MR angiography with aortic spin labeling: initial experience. Radiology 2002, 225:589-596. 10.1148/radiol.2252011366, 12409599.
57. Ritt M, Janka R, Schneider MP, Martirosian P, Hornegger J, Bautz W, Uder M, Schmieder RE. Measurement of kidney perfusion by magnetic resonance imaging: comparison of MRI with arterial spin labeling to para-aminohippuric acid plasma clearance in male subjects with metabolic syndrome. Nephrol Dial Transplant 2010, 25:1126-1133. 10.1093/ndt/gfp639, 19934080.
58. Fenchel M, Martirosian P, Langanke J, Giersch J, Miller S, Stauder NI, Kramer U, Caussen CD, Schick F. Perfusion MR imaging with FAIR true FISP spin labeling in patients with and without renal artery stenosis: initial experience. Radiology 2006, 238:1013-1021. 10.1148/radiol.2382041623, 16439565.
59. Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grandle JP, Gomex SI, Romero JC. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008, 19:780-788. 10.1681/ASN.2007040420, 2390957, 18287564.
60. Warner L, Glockner JF, Woollard J, Textor SC, Romero JC, Lerman LO. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol 2011, 46:41-47. 10.1097/RLI.0b013e3181f0213f, 3006042, 20856128.
61. Pruijm M, Hofmann L, Maillard M, Tremblay S, Glatz N, Wuerzner G, Burnier M, Vogt B. Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 2010, 55:1116-1122. 10.1161/HYPERTENSIONAHA.109.149682, 20308608.
62. Heine GH, Gerhart MK, Ulrich C, Kohler H, Girndt M. Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 2005, 68:878-885. 10.1111/j.1523-1755.2005.00470.x, 16014069.
63. Wan L, Yang N, Hiew CY, Schelleman A, Johnson L, May C, Bellomo R. An assessment of the accuracy of renal blood flow estimation by Doppler ultrasound. Intensive Care Med 2008, 34:1503-1510. 10.1007/s00134-008-1106-8, 18408915.
64. Lerolle N, Guerot E, Faisy C, Bornstain C, Diehl JL, Fagon JY. Renal failure in septic shock: predictive value of Doppler-based renal arterial resistive index. Intensive Care Med 2006, 32:1553-1559. 10.1007/s00134-006-0360-x, 16941165.
65. Rodrigo E, Lopez-Rasines G, Ruiz JC, Lastra P, Gómez-Dermitt V, Gómez-Alamillo C, González-Coturruelo J, Calabia A, Arias M. Determinants of resistive index shortly after transplantation: independent relationship with delayed graft function. Nephron Clin Pract 2010, 114:c178-186. 10.1159/000262300, 19955823.
66. Schneider A, Johnson L, Goodwin M, Schelleman A, Bellomo R. Bench-to-bedside review: Contrast enhanced ultrasonography - a promising technique to assess renal perfusion in the ICU. Crit Care 2011, 15:157. 10.1186/cc10058, 3218962, 21586101.
67. Romero JR, Frey JL, Schwamm LH, Damaerschalk BM, Chaliki HP, Parikh G, Burke RF, Babikian VL. Cerebral ischemic events associated with "bubble study" for identification of right to left shunts. Stroke 2009, 40:2343-2348. 10.1161/STROKEAHA.109.549683, 19498192.
68. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol 2008, 102:1 742-1746.
69. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D, Bierig M, Mulvagh SL, Porter TR, Labovita AJ. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 2009, 53:32-38. 10.1016/j.jacc.2008.08.066, 19118722.
70. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998, 97:473-483. 10.1161/01.CIR.97.5.473, 9490243.
71. Kishimoto N, Mori Y, Nishiue T, Shibasaki Y, Iba O, Nose A, Uchiyama-Tanaka Y, Masaki H, Katsubara H, Iwasaka T. Renal blood flow measurement with contrast-enhanced harmonic ultrasonography: evaluation of dopamineinduced changes in renal cortical perfusion in humans. Clin Nephrol 2003, (59):423-428.
72. Schwenger V, Korosoglou G, Hinkel UP, Morath C, Hansen A, Sommerer C, Dikow R, Hardt S, Schmidt J, Kücherer H, Katus HA, Zeier M. Real-time contrast-enhanced sonography of renal transplant recipients predicts chronic allograft nephropathy. Am J Transplant 2006, 6:609-615. 10.1111/j.1600-6143.2005.01224.x, 16468973.
73. Benozzi L, Cappelli G, Granito M, Davoli D, Favali D, Montecchi MG, Grossi A, Torricelli P, Albertazzi A. Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 2009, 41:1214-1215. 10.1016/j.transproceed.2009.03.029, 19460520.
74. Schneider AG, Hofmann L, Wuerzner G. Renal perfusion evaluation with contrast-enhanced ultrasonography. Nephrol Dial Transplant 2012, 27:674-681. 10.1093/ndt/gfr345, 21690200.
75. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy: state of the art. Am J Hypertens 2010, 23:1159-1169. 10.1038/ajh.2010.174, 3078640, 20864945.